Your browser doesn't support javascript.
loading
The potassium channel Kcne3 is a VEGFA-inducible gene selectively expressed by vascular endothelial tip cells.
Deckelbaum, Ron A; Lobov, Ivan B; Cheung, Eunice; Halasz, Gabor; Rajamani, Saathyaki; Lerner, Julia; Tong, Chunxiang; Li, Zhe; Boland, Patricia; Dominguez, Melissa; Hughes, Virginia; Yancopoulos, George D; Murphy, Andrew J; Thurston, Gavin; Cao, Jingtai; Romano, Carmelo; Gale, Nicholas W.
Afiliación
  • Deckelbaum RA; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA. ron.deckelbaum@regeneron.com.
  • Lobov IB; Palmira Biopharma, Moscow, 143026, RF, Russia.
  • Cheung E; Department of Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Halasz G; Department of Bioinformatics, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Rajamani S; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Lerner J; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Tong C; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Li Z; Department of Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc., Tarrytown, NY, 10591, USA.
  • Boland P; Department of Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc., Tarrytown, NY, 10591, USA.
  • Dominguez M; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Hughes V; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Yancopoulos GD; Department of Research, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Murphy AJ; Department of Research, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Thurston G; Department of Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc., Tarrytown, NY, 10591, USA.
  • Cao J; Department of Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Romano C; Department of Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Gale NW; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
Angiogenesis ; 23(2): 179-192, 2020 05.
Article en En | MEDLINE | ID: mdl-31754927
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neovascularización Fisiológica / Canales de Potasio con Entrada de Voltaje / Células Endoteliales / Factor A de Crecimiento Endotelial Vascular / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Pregnancy Idioma: En Revista: Angiogenesis Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neovascularización Fisiológica / Canales de Potasio con Entrada de Voltaje / Células Endoteliales / Factor A de Crecimiento Endotelial Vascular / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Pregnancy Idioma: En Revista: Angiogenesis Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos